The WACC of Binh Dinh Pharmaceutical and Medical Equipment JSC (DBD.VN) is 8.4%.
| Range | Selected | |
| Cost of equity | 7.20% - 10.00% | 8.60% |
| Tax rate | 18.50% - 18.70% | 18.60% |
| Cost of debt | 4.00% - 4.50% | 4.25% |
| WACC | 7.1% - 9.8% | 8.4% |
| Category | Low | High |
| Long-term bond rate | 3.3% | 3.8% |
| Equity market risk premium | 8.3% | 9.3% |
| Adjusted beta | 0.48 | 0.61 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 7.20% | 10.00% |
| Tax rate | 18.50% | 18.70% |
| Debt/Equity ratio | 0.03 | 0.03 |
| Cost of debt | 4.00% | 4.50% |
| After-tax WACC | 7.1% | 9.8% |
| Selected WACC | 8.4% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for DBD.VN:
cost_of_equity (8.60%) = risk_free_rate (3.55%) + equity_risk_premium (8.80%) * adjusted_beta (0.48) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.